Navigation Links
Genomma Lab Internacional Acquires UNIGASTROZOL
Date:7/29/2008

MEXICO CITY, July 29 /PRNewswire-FirstCall/ -- Genomma Lab Internacional, S.A.B. de C.V. (BMV: LAB) ("Genomma" or "the Company"), a leading Mexican over-the-counter pharmaceuticals and personal care products company announced yesterday that it had acquired the brand and related rights and registrations of UNIGASTROZOL, from Unipharm de Mexico, S.A. de C.V. This over-the-counter product is used for the reduction and control of gastrointestinal symptoms that are produced by excessive acid secretion and is also helpful in the treatment of gastritis, heartburn, reflux and esophagitis. It is based on a molecule that allows for faster absorption than that of Omeoprazol.

With this acquisition, Genomma Lab complements its line of anti-acid products, in particular its product Genoprazol. The category under which Unigastrozol participates reached sales of over US$ 50 million in 2007.

This is Genomma's first acquisition since listing on the Mexican Stock Exchange in June, when it raised capital seeking to accelerate growth.

Company Description

Genomma Lab Internacional, S.A.B. de C.V. is one of the fastest growing over-the-counter pharmaceutical and personal care products companies in Mexico and has a growing international presence. Genomma develops, sells and markets a broad range of premium branded products, many of which are leaders in the categories in which they compete in terms of sales and market share. The Company has significantly grown its revenue and profitability through a combination of a successful new product development process, consumer-oriented marketing, a broad retail distribution network and a low-cost, highly flexible operating model.

Genomma's shares are listed on the Mexican Stock Exchange under the ticker symbol "LAB".

Web Site: http://www.genommalab.com

Contact in Mexico City: Kristi King Etchberger, CFO; kking@genommalab.com; Tel. (55) 5081 0
'/>"/>

SOURCE Genomma Lab Internacional, S.A.B. de C.V.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Genomma Lab Prices Initial Public Offering and Begins Trading on Mexican Stock Exchange
2. Webcast Alert: Genomma Lab Internacional, S.A.B. de C.V. announces Second Quarter 2008 Results Conference Call
3. Cogdell Spencer Inc. Acquires Summit Professional Plaza I and II in Brunswick, Georgia
4. Omnicom Acquires Leading Healthcare Marketing Communications Firm in China
5. Food Bank For New York City Acquires FoodChange
6. Concentra Acquires Assets of Renew Health & Wellness
7. DaVita Acquires Majority Stake in HomeChoice Partners, Inc.
8. NNN Healthcare/Office REIT Acquires St. Mary Physicians Center in Long Beach, California
9. NNN Healthcare/Office REIT Acquires 2750 Monroe Boulevard in Valley Forge, Pennsylvania
10. Hologic Acquires Biolucent, Inc.
11. Radiation Therapy Services Acquires North Carolina Facility
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2009)--In Youngest Babies, This Type of Blood Cancer Is Most Challenging-- ,, PHILADELPHIA and NEW ORLEANS, Dec. 5 Pediatric oncologists have identified specific genes, dubbed partner genes, that fuse w
(Date:12/5/2009)AVIVA today announced the launch of International Solutions, an innovative new international private medical insurance plan which follows the acclaimed modular design of its UK equivalent. In addition
(Date:12/4/2009)NEW YORK, Dec. 4 Thousands of KPMG LLP employees came together in more than 90 offices nationwide today, to participate in a community service event which combines the audit, tax and advisory firm,s
(Date:12/4/2009)KANSAS CITY, Mo., Dec. 4 The large, two-day free health clinic sponsored by the National Association of Free Clinics (NAFC) in Kansas City on Wednesday and Thursday is not just for the sick but also
(Date:12/4/2009)Late recurrence is a risk for some pediatric cancers, particularly Ewing sarcomas and tumors of the central nervous system, according to a new study published online December 4 in the Journal of the
Breaking Medicine News(10 mins):Health News:New Gene Findings Will Help Guide Treatment in Infant Leukemia 2Health News:New Gene Findings Will Help Guide Treatment in Infant Leukemia 3Health News:New Gene Findings Will Help Guide Treatment in Infant Leukemia 4Health News:AVIVA's Private Health Insurance Products Solutions Go International 2Health News:KPMG Employees Provide 'Holiday Bear Hugs' and Books in Firmwide Service Day for Children 2Health News:Free Health Clinic Event Is Not Just for the Sick 2
..., According to the comSco...tp://www.HealthGuru.com ) was the fastest growing ... Not coincidentally, Health Guru was also one of ...09 -- According to the comScore, Inc. February ran...
..., NEW ORLEANS, April 7 CareRise, a risk managemen...skilled nursing and rehab facilities, assisted liv... by the U.S. Department of Health & Human Serv... for the Agency for Healthcare Research and Qualit...
..., , Video killed the radio star, the old song goes...ty study finds, can also improve the real-world vi...brain scientist, I was quite concerned when my kid...of Rochester to carry out the new study. "What we ...
..., User Centric Announces Syndicated Research for U... April 7 In response to the growing need for unde...ds (EHRs), User Centric ( www.usercentric.com ) ...of the key limiting factors to adoption now is usa...
...The flavored drinks should carry warning labels, s... (HealthDay News) -- Flavored alcoholic beverages ...ing and should carry warning labels, say many Amer...alcopops have between 5 and 8 percent alcohol cont...
..., Rockville, Md., April 7, 2009 Aiming to improv...on and the United States, two leading drug quality...plans to work together on standards-related activi... captured in a Memorandum of Understanding (MOU) s...
Other Medicine News:Health News:Web's Fastest Growing Health Site is a Video Site 2Health News:Web's Fastest Growing Health Site is a Video Site 3Health News:U.S. Department of Health and Human Services Names CareRise a Patient Safety Organization 2Health News:Violent video games can improve vision 2Health News:EMRs Put to the Test on Usability 2Health News:EMRs Put to the Test on Usability 3Health News:Parents Worry That 'Alcopops' Encourage Teen Drinking 2Health News:US, Russian organizations team to improve the quality of medicines 2Health News:US, Russian organizations team to improve the quality of medicines 3
(Date:12/4/2009)WASHINGTON, Dec. 4 Chemistry World recently highlighted a new report published by the Pharmaceutical Research and Manufacturers of America ( PhRMA ) that identifies 97 new drugs and vaccines in
(Date:12/4/2009)BILLERICA, Mass., Dec. 4 Axsun Technologies, Inc., a wholly-owned subsidiary of Volcano Corporation (Nasdaq: VOLC ), today announced the initial development and successful testing of a novel integra
(Date:12/4/2009)BETHESDA, Md., Dec. 4 Northwest Biotherapeutics, Inc. ("NWBT" or the "Company") (OTC Bulletin Board: NWBO) announced today that the US Patent and Trademark Office has allowed its patent application o
Breaking Medicine Technology:U.S. Pharmaceutical Companies Developing 97 New Drugs and Vaccines to Fight HIV/AIDS 2Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging 2Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging 3Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging 4Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging 5Northwest Biotherapeutics Receives Approval of US Patent for Cost Saving Automation of High-Concentration DCVax(R) Manufacturing 2Northwest Biotherapeutics Receives Approval of US Patent for Cost Saving Automation of High-Concentration DCVax(R) Manufacturing 3Northwest Biotherapeutics Receives Approval of US Patent for Cost Saving Automation of High-Concentration DCVax(R) Manufacturing 4Northwest Biotherapeutics Receives Approval of US Patent for Cost Saving Automation of High-Concentration DCVax(R) Manufacturing 5Accumetrics Announces 2416 5M in New Capital Financing 5246 1Accumetrics Announces 2416 5M in New Capital Financing 5246 2Accumetrics Announces 2416 5M in New Capital Financing 5246 3Future diabetes treatment may use resveratrol to target the brain 58934 1Future diabetes treatment may use resveratrol to target the brain 58934 2Genedata Screener Supports Small Molecule Research at the Broad Institute of Harvard and MIT 14362 1Genedata Screener Supports Small Molecule Research at the Broad Institute of Harvard and MIT 14362 2Genedata Screener Supports Small Molecule Research at the Broad Institute of Harvard and MIT 14362 3Genedata Screener Supports Small Molecule Research at the Broad Institute of Harvard and MIT 14362 4
...TON, Feb. 6 The U.S. Agency for International D... to the people of Zimbabwe, who are in the midst o...omy, food shortages and the cholera epidemic have ...lth risks. , , USAID, through the President,s M...Residual Spraying (IRS) to shore up gaps in the co...
...., Feb. 6 Johnson & Johnson Pharmaceutical R...ay announced that the company has submitted multip...ration (FDA) which, if approved, would broaden tre...hrenia or schizoaffective disorder. , , Earlier t...e FDA complete response letter for paliperidone pa...
Other Medicine Technology:USAID Provides Malaria Assistance to Zimbabwe 2Johnson & Johnson Pharmaceutical Research & Development, L.L.C. Announces FDA Filings for Paliperidone Palmitate and INVEGA(R) 2Johnson & Johnson Pharmaceutical Research & Development, L.L.C. Announces FDA Filings for Paliperidone Palmitate and INVEGA(R) 3Johnson & Johnson Pharmaceutical Research & Development, L.L.C. Announces FDA Filings for Paliperidone Palmitate and INVEGA(R) 4Johnson & Johnson Pharmaceutical Research & Development, L.L.C. Announces FDA Filings for Paliperidone Palmitate and INVEGA(R) 5
... offer clinical features to meet any testing requi...y for paperless storage. Flexible, affordable, and...CG software turns any computer into a powerful str...ith leading EMR systems, the family of Welch Allyn...
Q4500 Stress Test Monitor System
Q-Stress Cardiac Stress System
... from Del Mar Reynolds Medical. Available as a tur...ter, PC, Cart, isolation transformer and a non-inv...ient interface module that is used for resting ECG...ardioCollect as the patient interface module, allo...
Medicine Products: